Swiss drugmaker Roche, under pressure to increase output of its antiviral drug Tamiflu as the avian flu reaches Europe, is considering allowing other medical firms to make the drug.

It is willing to discuss all options to increase output of the treatment, including granting sub-licenses to produce Tamiflu for emergency pandemic use to governments and other companies.

Humana Inc. announces Tuesday it has reached an agreement with representatives of more than 700,000 physicians to settle a nationwide class action suit that has been pending in U.S. District Court in Miami for more than six years. The agreement is now pending approval in U.S. District court.

Pursuant to the settlement, Humana agrees to pay $40 million to physicians. In addition, Humana has agrees to pay up to $18 million in legal fees to be determined by the court.

The frightening prospects of an epic pandemic of bird flu (Avian flu) leads to a rush on protective masks across the U.S.

Custom Browser Inc., a distributor of N95 face masks reports a dramatic spike in sales in recent weeks in light of the Avian Flu news. The firm, which usually sells a few cases a month of the popular 3M 9211, 3M 9210, 3M 8233 N100, 3M 1860, 3M 1870 and 3M 8210 masks, now reports its nearly impossible to keep up with demand.

The promise of a new interactive Web site launching promises to make you happy. It's based on more than 40-years of clinical research from the world's foremost authority on positive psychology, Dr. Martin Seligman.

The new site, www.reflectivehappiness.com provides users with a series of scientifically tested exercises that have been clinically proven to decrease depression while improving emotional well being, allowing for more happiness in life.

Studies reveal that elderly adults with heart disease are less likely to receive aggressive treatment, than younger patients. In response, recent treatment guidelines have emphasized the fact that age alone should not determine whether emergency patients get blood-clot-dissolving drugs or invasive procedures.

However, the new study of patients at 443 U.S. hospitals, found that the older patients were, the less likely they were to receive these therapies -- even when their overall health was taken into account.